Perioperative Transfusion in Total Hip Arthroplasty: Predictive Factors and Outcomes.
9.4% of patients undergoing total hip arthroplasty required a blood transfusion.
Perioperative Transfusion in Total Hip Arthroplasty: Predictive Factors and Outcomes.
Total hip arthroplasty is a common orthopedic procedure with significant hemorrhagic risks, often necessitating postoperative transfusions to treat anemia.
Records of 3,865 patients who underwent primary total hip arthroplasty at a university center from 2002 to 2020 were retrospectively reviewed.
nearly 1 in 10 needed a transfusion after surgery
Transfusion rates decreased from 28.5% (2002-2003) to 11.3% (2004-2012) and 4.3% (2013-2020).
Multiple logistic regression showed that female sex, surgical indication, surgical approach, longer operative time, higher ASA scores, and greater postoperative hemoglobin drop significantly increased transfusion risk.
Conversely, tranexamic acid and anti-inflammatory use, and higher body weight significantly decreased transfusion risk.
Infection rates were higher among transfused patients (3%) compared to non-transfused patients (0.83%).
Reducing transfusion use is essential due to the scarcity of blood, associated costs, and complications, necessitating a standardized transfusion policy and perioperative care protocols.
Optimizing preoperative hemoglobin, using controlled hypotension anesthesia, minimally invasive surgical approaches, consistent surgical techniques, perioperative tranexamic acid, and postoperative anti-inflammatory use are crucial to reducing.